Esperion Therapeutics Stock (NASDAQ: ESPR)

Esperion Therapeutics

ESPERION THERAPEUTICS INC

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADAP

AILE

AIMD

ANTE

CMAX

ESPR

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

HUMA

LGMK

MMAT

NDRA

PSIG

SNOA

TNON

YMAB

Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket

xr:d:DAFl_HSvCpE:2,j:6755793051000407071,t:23061612

Intraday Update

ALUR

APLD

ASNS

BILI

DMTK

FEMY

GRDI

HIMX

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HROW

IBRX

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

KAVL

LOBO

LRHC

MBIO

MGOL

MOLN

NKLA

NLSP

NNVC

NYAX

OCUL

PACK

PRST

RELI

SLNH

SMCI

SONN

SRFM

SVMH

TBLT

Tempest Therapeutics, Inc. - Common Stock

TPST

TRVN

VNDA

ZAPP

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

workday shutter2

Price Target

Analyst Ratings

CROX

STTK

WDAY

Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics Inc

ESPRE TECHNOLOGIES INC B by ESPRE TECHNOLOGIES INC

Espre Technologies Inc

ESPRIT HOLDINS LTD by Esprit Holdings Ltd.

Esprit Holdings Ltd

ESPRIT HLDGS S/ADR by Esprit Holdings Ltd.

Press Releases

Esperion to Participate in The Citizens Life Sciences Conference

Earnings

Esperion Reports First Quarter 2025 Financial Results

Health Care

General

Esperion Partners with HLS Therapeutics to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Canada

HLS Therapeutics partners with Esperion Therapeutics to commercialize NEXLETOL® and NEXLIZET® in Canada

HLS Therapeutics Announces Q1 2025 Financial Results

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Esperion to Participate in H.C. Wainwright's 3rd Annual BioConnect Investor Conference

Contracts

Esperion Reaches Settlement Agreement with ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040

Esperion to Participate in Upcoming June Investor Conferences

Legal

Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040

TSX:HLS

Aardvark Therapeutics, Inc. - Common Stock

Aardvark Therapeutics

Aurora Cannabis

Aclaris Therapeutics, Inc. - Common Stock

Aclaris Therapeutics

Alumis

ALT5 Sigma

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics

Atea Pharmaceuticals, Inc. - common stock

Atea Pharmaceuticals

Bioage Labs

Biote

Canopy Growth Corporation - Common Shares

Canopy Growth

Cybin

Journey Medical Corporation - Common Stock

Journey Medical

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

High Tide

MBX Biosciences

MediWound

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics

Organigram Global

Omeros

scPharmaceuticals

SNDL

Terns Pharmaceuticals, Inc. - Common Stock

Terns Pharma

Third Harmonic Bio

Tvardi Therapeutics

Ventyx Biosciences

HC Wainwright & Co.

Needham

Goldman Sachs

Citizens Capital Markets

JMP Securities

Comments

Esperion Therapeutics

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell